Publications in collaboration with researchers from Hacettepe University (15)

2024

  1. Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies

    CardioVascular and Interventional Radiology, Vol. 47, Núm. 3, pp. 310-324

2023

  1. Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study

    JHEP Reports, Vol. 5, Núm. 2

  2. Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial

    JHEP Reports, Vol. 5, Núm. 5

  3. Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study

    CardioVascular and Interventional Radiology, Vol. 46, Núm. 7, pp. 852-867

2022

  1. Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial

    European Radiology, Vol. 32, Núm. 2, pp. 1320-1329

  2. Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial

    Biomedicines, Vol. 10, Núm. 5

  3. Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort

    Current Oncology, Vol. 29, Núm. 2, pp. 565-577

  4. Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

    Journal of Cancer Research and Clinical Oncology, Vol. 148, Núm. 9, pp. 2487-2496

  5. Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT

    Clinical Colorectal Cancer, Vol. 21, Núm. 4, pp. 285-296

  6. Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma

    British Journal of Cancer, Vol. 126, Núm. 2, pp. 211-218

2021

  1. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)

    CardioVascular and Interventional Radiology, Vol. 44, Núm. 1, pp. 21-35

  2. Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma

    Journal of Hepatology, Vol. 75, Núm. 6, pp. 1387-1396

  3. Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France

    CardioVascular and Interventional Radiology, Vol. 44, Núm. 1, pp. 36-49

2020

  1. Clinical application of radioembolization in hepatic malignancies: Protocol for a prospective multicenter observational study

    JMIR Research Protocols, Vol. 9, Núm. 4

2015

  1. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: Analysis of the European multicentre trial SORAMIC

    Liver International, Vol. 35, Núm. 2, pp. 620-626